epcoritamab
abbvie,genmab
['lymphoma', 'dlbcl']
epco data at #eha22: high and consistent orr/cr across all high risk subgroups. interesting analysis in 3l+ dlbcl on mrd- and os curve seems to be flattening. wonder how ctdna/mrd- will evolve in large-cell lymphoma. 
Opinions are my own: Former GLG Council Member (Oncology, IO, CAR T) ??Help Save Lives in Ukraine Donate to @Mriya_Aid at https://t.co/21PBkhfRVx ????